If you’ve had your thyroid removed, your TSH target generally falls between 0.3 and 4.5 mIU/L when the surgery was for a non-cancerous condition. If the reason was thyroid cancer, your target may be significantly lower, sometimes below 0.5 or even below 0.1, depending on your cancer risk level and how well treatment has worked. The right number for you depends on why your thyroid was removed, your age, and your overall health.
TSH Targets Without Cancer
When your thyroid was removed for a benign reason, such as an enlarged goiter, Graves’ disease, or large nodules, the goal is straightforward: replace the hormones your thyroid would have made and keep your TSH in the normal reference range. That range is generally 0.3 to 4.5 mIU/L, though the exact numbers can vary slightly between labs. Most doctors aim for a TSH somewhere in the lower half of that range, roughly 0.5 to 2.5, because many people feel best there. But the “right” number is the one where your symptoms are well controlled, your energy is stable, and you feel like yourself.
Without a thyroid, your body produces essentially no thyroid hormone on its own. Every bit of it comes from your daily levothyroxine pill. That means your TSH is entirely a reflection of whether your dose is too high, too low, or just right. A rising TSH signals your body wants more thyroid hormone. A very low TSH means you’re getting more than you need.
TSH Targets After Thyroid Cancer
Thyroid cancer changes the equation. Thyroid-stimulating hormone doesn’t just regulate metabolism; it also stimulates thyroid tissue to grow, including any remaining cancer cells. So after cancer surgery, doctors often intentionally push TSH below the normal range to reduce the chance of recurrence. How far below depends on how aggressive your cancer was and how your body has responded to treatment.
The 2015 American Thyroid Association guidelines, which remain widely used and were updated in 2025, break this into risk categories:
- High-risk patients: Initial TSH suppression below 0.1 mIU/L. This is an aggressively low target meant to starve any remaining cancer cells of growth signals.
- Intermediate-risk patients: TSH between 0.1 and 0.5 mIU/L.
- Low-risk patients who’ve had remnant ablation: TSH between 0.1 and 0.5 mIU/L initially, potentially relaxing to 0.5 to 2.0 mIU/L once blood markers show no evidence of disease.
- Low-risk patients after lobectomy (partial removal): TSH in the mid to lower reference range, roughly 0.5 to 2.0 mIU/L.
The 2025 ATA update emphasizes that TSH suppression should be individualized. The decision to keep TSH below normal should weigh the potential cancer benefit against the real health risks of long-term suppression. High-risk patients are most likely to benefit from very low TSH levels. For patients who’ve had an excellent response to treatment with no detectable markers, the updated guidelines recommend bringing TSH back into the normal reference range rather than continuing suppression indefinitely.
Why an Overly Low TSH Is Risky
Keeping TSH suppressed below normal essentially puts your body in a state of mild hyperthyroidism. Your lab work might show normal levels of the active thyroid hormones, but your pituitary gland is signaling that there’s too much. Over months and years, this takes a measurable toll on two systems in particular.
The heart is especially vulnerable. A TSH below 0.1 mIU/L increases the risk of atrial fibrillation, a type of irregular heartbeat that can lead to heart failure and stroke. The risk rises with age, which is why doctors are more cautious about aggressive suppression in older adults. Heart failure and overall mortality also increase at very low TSH levels.
Bone density is the other major concern. Overtreatment with levothyroxine is one of the primary risk factors for accelerated bone loss, particularly in postmenopausal women. Studies consistently link suppressed TSH to lower bone mineral density and a higher fracture risk. This is why the trend in thyroid cancer care has shifted toward relaxing TSH targets once the initial high-risk period has passed, rather than maintaining suppression for life.
How Often to Test TSH
After any dose change, your TSH needs at least six weeks to stabilize before retesting gives an accurate reading. TSH responds slowly because it reflects your average thyroid hormone levels over weeks, not days. Testing too soon after a dose adjustment will give you a number that’s still in transition and could lead to unnecessary further changes.
Once you’re on a stable dose and feeling well, most doctors check TSH every six to twelve months. If you’ve had thyroid cancer, the monitoring schedule is typically more frequent in the first few years, then gradually stretches out as your results remain reassuring. Any significant change in your health, weight, or other medications is a good reason to recheck sooner.
What Can Throw Off Your Results
A few common things can make your TSH reading inaccurate, which matters a lot when your entire treatment depends on that number.
Biotin supplements are the biggest offender. Biotin, also labeled as vitamin B7, is found in many hair, skin, and nail supplements, sometimes in doses high enough to interfere with thyroid blood tests. In sandwich-style assays (the kind used to measure TSH), excess biotin in your blood can cause a falsely low TSH reading. That could make it look like you’re overmedicated when you’re actually fine. If you take biotin, stop it for at least several days before your blood draw.
Calcium and iron supplements can interfere with your actual thyroid hormone levels rather than the test itself. Both minerals bind to levothyroxine in your gut and reduce how much gets absorbed. The standard advice is to take your levothyroxine on an empty stomach, at least 30 to 60 minutes before eating, and to separate it from calcium or iron by at least four hours. If you’re inconsistent with this, your TSH can bounce around from one test to the next.
Finding Your Personal Target
Reference ranges are a starting point, not a destination. Two people with no thyroid can have very different ideal TSH levels. Some feel best at 1.0, others at 2.5. The numbers that matter are the ones where you sleep well, think clearly, maintain a stable weight, and have enough energy to get through your day.
If your TSH is technically “in range” but you still feel exhausted, foggy, or not right, that’s worth a conversation about whether your target should shift. Some providers will also check free T4 levels alongside TSH to get a more complete picture of how well your replacement dose is working. TSH alone tells you whether the dose is broadly correct, but free T4 shows how much active hormone is actually circulating.
For thyroid cancer patients, the target is a moving window. It starts more aggressive and loosens over time as your response to treatment becomes clear. The goal is to spend as little time as necessary at suppressed levels while still protecting against recurrence. That balance looks different for every person, which is why the most current guidelines frame TSH targets as a conversation rather than a fixed number.